Source: Abbott | May 02, 2019

Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test

Confirms that the m-PIMA™ HIV-1/2 VL meets global standards of quality, safety and efficacy

WHO Prequalification approval allows Abbott (www.Abbott.com) to bring critical technology to more resource-limited settings; confirms that the m-PIMA™ HIV-1/2 VL meets global standards of quality, safety and efficacy Abbott announced today that m-PIMA™ HIV-1/2 VL (https://abbo.tt/2IUTDwL), the world's first point-of-care viral load diagnostic test, has received the World Health Organization's…